The TeraPore Technology co-founder and CEO is featured in the 2024 Faces of American Innovation Report along with four other honorees selected to receive the award.
The study paves the way for using the novel manufacturing process and quality controls to move cell therapy production further along toward applying it in a clinic.
Research at Weill Cornell Medicine suggests that childhood immunization against HIV could one day provide protection before risk of contracting the potentially fatal infection dramatically increases in adolescence.
The study shows that artificial intelligence and machine learning technologies can effectively and efficiently subtype pathology samples from patients with rheumatoid arthritis.
Study opens the door to exploring new targets for therapies for fibrolamellar carcinoma, which does not respond to conventional treatments and leaves patients with approximately a year to live on average once it is detected.
